System and Method for Promoting Instrinsic Conduction Through Atrial Timing Modification and Calculation of Timing Parameters
First Claim
Patent Images
1. A method comprising:
- operating an implantable medical device according to a ventricular pacing protocol (VPP) wherein ventricular pacing is precluded in a given cardiac cycle where a ventricular event occurred in a cardiac cycle immediately prior to the given cardiac cycle;
establishing an A-A interval;
initiating a first AV interval timer at the initiation of the given cardiac cycle;
sensing for ventricular events;
scheduling an early atrial pacing pulse at an accelerated atrial interval (AP(E)) prior to the termination of the A-A interval if no ventricular event is sensed within the duration of the AV interval timer, wherein the A-AP(E) interval is ≧
the AV interval timer, is ≦
a lower rate interval (LRI), and the AP(E) is selected to lead to a likely ventricular event (Target VS) at a predetermined time.
1 Assignment
0 Petitions
Accused Products
Abstract
An atrial based pacing protocol promotes intrinsic conduction. An entire cardiac cycle is monitored for ventricular activity and permitted to lapse with ventricular activity. Ventricular pacing is available in a cardiac cycle immediately subsequent to such a skipped beat. When monitoring for intrinsic ventricular events, an event is expected within a given window. If no such event is detected, the cardiac cycle in truncated, leading to a shorter cycle that is devoid of ventricular activity. The subsequent cycle has a high likelihood of a ventricular sensed event and a greater than normal AV interval is provided prior to pacing.
-
Citations
18 Claims
-
1. A method comprising:
-
operating an implantable medical device according to a ventricular pacing protocol (VPP) wherein ventricular pacing is precluded in a given cardiac cycle where a ventricular event occurred in a cardiac cycle immediately prior to the given cardiac cycle; establishing an A-A interval; initiating a first AV interval timer at the initiation of the given cardiac cycle; sensing for ventricular events; scheduling an early atrial pacing pulse at an accelerated atrial interval (AP(E)) prior to the termination of the A-A interval if no ventricular event is sensed within the duration of the AV interval timer, wherein the A-AP(E) interval is ≧
the AV interval timer, is ≦
a lower rate interval (LRI), and the AP(E) is selected to lead to a likely ventricular event (Target VS) at a predetermined time. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. An implantable medical device comprising:
-
means for operating an implantable medical device (IMD) according to a ventricular pacing protocol (VPP) wherein ventricular pacing is precluded in a given cardiac cycle wherein a ventricular event occurred in a cardiac cycle immediately subsequent to the given cardiac cycle; means for establishing an A-A interval; means for initiating a first AV interval timer at the initiation of the given cardiac cycle; means for sensing for ventricular events; means for scheduling an early atrial pacing (AP(E) pulse prior to the termination of the A-A interval if no ventricular event is sensed within the duration of the AV interval timer, wherein the A-AP(E) interval is ≧
the AV interval timer, is ≦
a lower rate interval (LRI), and the AP(E) is selected to lead to a likely ventricular event (Target VS) at a predetermined time. - View Dependent Claims (14, 15, 16, 17, 18)
-
Specification